Abstract Hyperglycemic emergencies such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic states (HHS) have a significant impact on morbidity and mortality. Patients with type 1 and type 2 diabetes are at risk for developing these severe metabolic complications and often present to the emergency department requiring fluid management, electrolyte replacement, and insulin therapy for rapid and safe reversal. Early identification of hyperglycemic patients with the use of point-of-care (POC) testing may facilitate implementation of an institutional treatment algorithm in those patients presenting with DKA and HHS. There are limited studies evaluating the use of POC testing for early identification of hyperglycemic emergencies and the utilization of a standardized insulin protocol. The aim of this article is to review the literature evaluating POC testing and its applicability for implementation of institutional hyperglycemic emergency protocols in the emergency department.
Introduction
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are severe metabolic complications often seen in patients with type 1 and type 2 diabetes [1].
DKA is typically associated with type 1 diabetes and is most common in young diabetic patients [2] . The overall mortality rate of DKA is around 1 % and higher rates are seen in patients who are elderly or those with co-morbid conditions. HHS is typically associated with type 2 diabetes and account for approximately 1 % of all primary diabetic admissions. Mortality rates in HHS have been reported as high as 20 % in developed countries [3] . Treatment algorithms are tools that aid in identifying and facilitate treatment in those patients experiencing DKA and HHS. Many have incorporated point-of-care (POC) testing to expedite critical laboratory results and lead to early treatment initiation [4] . While these tests have been shown to be reliable and accurate, few studies have demonstrated benefit of POC glucose measurements.
Objective
Since many patients with diabetic complications present to emergency departments (ED) for care, the aim of our article is to evaluate the literature surrounding POC testing and treatment algorithms that facilitate management of those patients with hyperglycemic emergencies.
Methodology
We completed a literature search containing the terms ''point-of-care testing,'' ''diabetic ketoacidosis,'' ''hyperosmolar hyperglycemic state,'' ''protocols,'' ''care pathways'', ''guideline,'' ''order set,'' and ''emergency department.'' We limited our results to the last two decades and to those articles in the English language.
Results
Several studies have evaluated ED-based POC testing in DKA and HHS (Table 1) . A study evaluating continuous glucose monitoring systems (CGMS) in the ED proved to have an overall clinical accuracy of 96.8 % and in agreement with capillary glucose testing levels [5] . However, CGMS demonstrated limited real-time detection of hypoglycemia. In detecting hypoglycemia, CGMS had a sensitivity and positive predictive value of 33.3 % and 16.7 %, respectively [5] . This study suggests CGMS in the ED may be beneficial in identifying hyperglycemia, however, may not be accurate in identifying hypoglycemia. Charles et al. [6] determined that a beta-hydroxybutyrate (b-OH) level of [ 3.5 mmol/L was 100 % sensitive and specific for a diagnosis of DKA. With that, POC testing for blood ketones is a more sensitive and specific method than a urine sample for diagnosing DKA. In addition, there was a faster test turnaround time (TAT) with POC blood ketone testing. Arora et al. [7] evaluated POC testing of b-OH for assessing DKA severity. This prospective study included 54 patients with an initial diagnosis of DKA. The mean POC b-OH for the patients with DKA was 4.9 mmol/L (IQR 3.7-5.6). The correlation coefficients between b-OH and pH, bicarbonate, and anion gap were 0.33, 0.25, and 0.16, respectively [7] . The study concluded that POC b-OH had modest correlation to serum measurements, however, could not be used to reliably assess the severity of DKA. Arora et al. also studied the accuracy of POC testing for b-OH versus traditional urine dipstick. This prospective study included 54 DKA patients, meeting diagnosis criteria consistent with the American Diabetes Association (ADA), presenting to the ED. The urine dipstick had a sensitivity of 98.1 % (95 % CI 90.1-100), a specificity of 35.1 % (30.7-39.6), a positive predictive value of 15 % (11.5-19.2), and a negative predictive value of 99.4 % (96.6-100) for DKA [19] . Using the manufacturer-suggested cutoff of [1.5 mmol/L, b-OH had a sensitivity of 98.1 % (90.1-100), a specificity of 78.6 % (74.5-82.2), a positive predictive value of 34.9 % (27.3-43), and a negative predictive value of 99.7 % (98.5-100) for DKA [8] . The study concluded that POC b-OH and the urine dipstick are equally sensitive for detecting DKA; however, b-OH is more specific [7, 8] .
Several studies have evaluated ED-based POC testing in conditions unrelated to DKA and HHS (Table 2) . Sen et al. [9] compared the accuracy of quantitative D-dimer results using a POC testing device against standard laboratory testing in patients with suspected venous thromboembolism (VTE) in the ED. The results showed that there was strong evidence of POC D-dimer being sufficiently accurate to be used as a screening device. D-dimer TAT decreased by [9] . The mean POC TAT was 15 min compared with a lab TAT of 90 min with a mean ED length of stay (LOS) of 3 h and 6 min [9] . The study concluded that the POC D-dimer machine is an effective and safe screening tool, which can be implemented in EDs [9] . Lee-Lewandrowski et al. [10] found that the implementation of a POC testing laboratory in the ED led to faster test TAT for blood glucose, urine human chorionic gonadotropin, urine dipstick, creatine kinase-MB, and troponin tests. This also led to a decreased LOS in the ED, and improved clinician satisfaction with test accuracy and TAT.
Literature Review for Critical Pathway or Guideline
Waller et al. [11] determined that an integrated care pathway for DKA resulted in significant improvements in time to initiation of intravenous fluids Devalia and colleagues discovered that protocol-driven DKA management led to appropriate fluid resuscitation in 80 % of patients, and appropriate insulin administration in 72 % of patients. They also found that clinicians followed the DKA protocol during the first hour of treatment [12] .
Bull et al. [13] assessed the effect of a mandatory protocol for ICU DKA management at an academic medical center. The protocol was implemented by means of education and an order set that provided orders for the nurse to manage patient monitoring, fluid resuscitation, insulin and dextrose infusion, and electrolyte repletion. Implementation of a mandatory, comprehensive protocol for treating DKA led to a shortened intensive care unit (ICU) LOS by 23 % and hospital LOS by 30 %. Patients treated with the protocol also had a shorter time to clearance of the anion gap and ketones with no difference in the number of hypoglycemic episodes before and after implementing the protocol [13] . A study by Beik and colleagues implemented an institution-wide guideline for both DKA and HHS and provided education to various disciplinary groups to ensure the wide spread use of the guideline and order sets for patients presenting with DKA or HHS. This education component was ongoing throughout their study to ensure continued use of the guideline and order sets [14 •• ] . Additionally, continuous quality improvement metrics are needed to improve guideline utilization and adherence. This ensures that any feedback or updates to improve current guidelines will be addressed [14 •• ] .
With the use of POC testing, timely identification and proper management of these hyperglycemic emergencies are essential to improve patient outcomes and provide good quality care. Beik and colleagues included all adult patients with a diagnosis of DKA and HHS before and after implementation of an institutional guideline and order set and who were admitted to the ICU or inpatient step-down units. The investigators of the study utilized initial glucose readings from POC testing to quickly identify patients who may need further DKA or HHS management [14 •• ]. POC glucose testing was then used as part of the hyperglycemia protocol to monitor glucose trends (Fig. 1) . They found improvements in ICU LOS (64.8 ± 19 vs. 37.1 ± 74.8 h, p \ 0.01) and laboratory assessments, including time to anion gap closure (13 ± 9 vs. 9.3 ± 7.4 h, p \ 0.01) [14 •• ] . They also saw an increase in the number of patients who received the recommended guideline weight-based insulin bolus dose prior to initiation of insulin infusion, dextrose administration according to guideline, increased frequency of POC glucose testing, and the guideline recommended transition to subcutaneous insulin in the postguideline and order set implementation group [14 •• ].
Discussion
Glucose POC testing in patients that present to the ED with suspicion of DKA or HHS is often utilized in our institution. In addition to timely glucose POC testing, patients presenting with hyperglycemic emergencies are initiated on a hospital wide hyperglycemic emergencies order set to guide providers through the appropriate treatment plan and monitoring parameters which include POC glucose testing.
In the 1970s and 1980s, early studies outlined the basis for current treatment strategies of DKA and HHS [15 •• ] . The mainstays of management: hydration, insulin therapy, and correction of electrolyte abnormalities have remained unchanged in the past 10 years [15 •• ]. The ADA has outlined best practices to treat both DKA and HHS and recommend fluid therapy to correct hypovolemia, insulin therapy to correct hyperglycemia, electrolyte repletion to correct electrolyte imbalances, and frequent laboratory monitoring to ensure successful resolution of DKA and HHS [16] . The ADA guidelines stress the importance of early recognition of these hyperglycemic crises, which lead to prompt initiation of intravenous hydration and appropriate insulin management [16] . Despite these recommendations, research has shown variations in practice and low adherence with clinical guidelines resulting in suboptimal DKA management [17, 18] . Several published studies have advocated the use of treatment protocols to improve DKA management [11] [12] [13] 14 Our literature review found that POC testing in the ED leads to faster TAT of critical results which aid clinical decisions and leads to a decreased LOS in the ED. When POC testing is implemented for patients presenting with a suspected hyperglycemic emergency, this is a rapid, accurate, and easy-to-use screening tool which also yields a quicker TAT of results and therefore, quicker decisionmaking for clinicians.
Protocol or Guideline Implemented Care
Appropriate identification of patients experiencing a hyperglycemic crisis can provide medical staff with the necessary tools to implement correct treatment algorithms. Long laboratory TAT can contribute to a delay in initiating therapy. Therefore, the need for timely lab measurements, such as POC testing can help expedite critical laboratory results leading to appropriate initiation of treatment protocols or guidelines. This is seen in the study by Beik et al. as POC testing is the initial critical laboratory result that leads clinicians to utilizing the hyperglycemic emergencies management order set in the ED. Additionally, with the use of the order set, which has POC testing every 2 h, they saw an increase in the frequency of POC testing in the POST group. With the routine use of POC testing, patients can be appropriately identified then quickly initiated on a treatment guideline that will standardize patient care in the ED.
Decision support tools are intended to deliver consistent patient care derived from evidence-based data. Decision support at the POC is crucial because they provide clinicians with specific instructions to assist in clinical decisions. Although the uses of guidelines and protocols have been shown to be effective, concerns about the threat to clinical judgment or differences in practice may be present.
Variability between clinicians is expected given diverse educational and practical backgrounds [20] . Given theses differences, protocols can prove useful in these situations when judiciously implemented to reduce inter-provider variability. Having protocols in place offers clinicians a tool that increases the likelihood that therapies are not overlooked or are implemented as intended. Most importantly patient safety may be enhanced due to consistent provider-to-provider transitions [21] .
Additional benefits to implementing institution-wide protocols for clinicians may include quick adoption of new evidence to the bedside, consistent patient care, educational support, improvements in communication, cost avoidance, and improvement in patient safety. The caveat to protocolized care is that they are initialized for the appropriate patient. Many protocols are derived from large studies with specific patient populations and clinical judgment should take into account determining if a patient is an appropriate candidate for a treatment protocol [20, 21] .
Clinicians should expect protocols within their own institutions to emphasize a multidisciplinary team-based approach with implementation by the proper identification of patients and incorporation of clinical decision-making tools. By implementing protocols that maintain clinician independence but minimize prescribing inconsistencies, care is more efficiently and effectively directed to improve patient outcomes.
Conclusion
POC testing allows results to be available immediately and relayed to all members of the medical team instantaneously and decreases TAT. Rapid provision of results may facilitate better clinical decision-making, appropriate use of clinical guidelines, which will lead to improved clinical outcomes.
